colleagues [16] showed that C3 fragments accumulate on the RBC membrane during storage of whole blood and that RBC survival was negatively correlated with both duration of storage and the amount of C3 deposition. When whole blood is separated followed by leukocyte depletion by filtration and storage of RBCs in SAGM, C3, C4 and C5 are undetectable in the RCC [17] . However, it has been reported that, despite leukoreduction, C3 is found on RBC membranes and soluble MAC levels are increased during RBC storage [13, 18] .
Here, we investigated to what extent antibody binding and complement activation occurred during RBC storage. Furthermore, by incubating stored RBCs with normal human serum (NHS), we studied whether opsonization with complement and/or antibodies may contribute to in vitro phagocytic uptake of RBCs by M1-and M2-type macrophages.
Material and Methods

Antibodies
Monoclonal antibody (mAb) anti-C3-19, anti-C4-10, and anti-DAF-1 are in-house generated mAbs [19] . Anti-C3-19 was DyLight 488-or DyLight 647-conjugated (Thermo Scientific, Rockland, IL, USA). Anti-C4-10 and anti-DAF-1 were DyLight 647-conjugated (Thermo Scientific). Polyclonal antibody anti-IgG-FITC was from Sanquin Reagents (Amsterdam, The Netherlands). Anti-CR1-PE (To5) was from Santa Cruz (Dallas, TX, USA) and anti-CD59-CF405M (VJ1/12.2) was from Abcam (Cambridge, UK).
Serum Samples
Normal human serum was drawn from 13 donors, after informed consent. Eight sera were pooled (NHS pool), of which an aliquot was heat-inactivated (HI-NHS) for 30 min at 56 ° C, 5 sera were individually aliquoted. All aliquots were stored at -80 ° C.
Isolation and Storage of RBCs
RBCs from RCCs, collected in a quadruple citrate phosphate dextrose (CPD)-SAGM top-and-bottom bag system (Composelect, Fresenius HemoCare, Emmer-Compascuum, the Netherlands), were used from the Dutch Sanquin Blood Supply Foundation after informed consent from the donors. Alternatively, RBCs were isolated from whole blood collected in sodium citrate tubes by centrifugation at 1,080 × g for 10 min. After removing plasma and peripheral blood mononuclear cells, RBCs were washed three times with PBS by centrifugation at 1,080 × g for 10 min (Fresenius Kabi, Zeist, the Netherlands) and stored as a 50% cell suspension in SAGM (Fresenius Kabi).
Both RCCs and RBCs from tubes were stored for a short (2-6 days) or long (35-40 days) time period at 2-6 ° C, and before use stored RBCs were washed with PBS to investigate the intrinsic capacity of the RBCs to bind antibodies and activate the complement system.
RBC Incubation with Human Serum for Complement Deposition and
Antibody Binding 0.16% RBCs in a final volume of 100 μl were incubated with 50% NHS or HI-NHS (v/v) diluted in veronal buffer (3 mmol/l barbital, 1.8 mmol/l sodium barbital, 145 mmol/l NaCl, pH 7.4) containing 0.05% gelatin (w/v), 10 mmol/l CaCl 2 , and 2 mmol/l MgCl 2 at 37 ° C overnight. To detect antibody binding, RBCs were incubated for 1 h at room temperature. Allogenic NHS was used, unless indicated otherwise. 
Phagocytosis Assay
A phagocytosis assay was performed as described before [20] . In short, M1-and M2-type macrophages were generated from human monocytes by stimulation for 9 days with 10 ng/ml GM-CSF (CellGenix, Freiburg i.Br., Germany) or 50 ng/ml M-CSF (eBioscience, Vienna, Austria). Subsequently, M1-and M2-type macrophages were incubated with NHS-opsonized or untreated carboxyfluorescein succinimidyl ester (CFSE)-labeled RBCs. As positive control, RBCs were opsonized with anti-RhD antibody. RBCs were added to M1-or M2-type macrophages for 2 h and 1 h, respectively. After incubation, nonphagocytosed RBCs were removed, using an isotonic ammonium chloride lysis buffer. Uptake of CFSE-labelled RBCs by macrophages was analyzed by FACS.
In addition, the cells were stained with May-Grünwald eosin-methylene blue modified solution (Merck) for 5 min and subsequently with Giemsa solution (Merck) for 30 min. Light micrographs were taken using a Axiovert Scope. A1 microscope (Zeiss, Oberkochen, Germany).
Statistics
Data were analyzed using GraphPad Prism (version 6; GraphPad Software, San Diego, CA, USA). To compare C3 deposition and IgG binding between short and long stored RBCs, a Wilcoxon test was performed. For the phagocytosis assay, a two-way Anova test and a post-test a Tukey multiple comparisons test was performed.
Results
Incubation of RBCs with Normal Human Serum Leads to C3 Deposition
To determine whether complement activation occurs on RBCs during isolation and storage, C3 and C4 deposition on RBC membranes were analyzed by flow cytometry. No C3 or C4 deposition was observed on the membranes of RBCs obtained from either RCCs or tubes that were stored for a short period or a long period ( fig. 1 A) .
Next, we incubated RBCs with allogeneic NHS as complement source. Using ABO mismatch as model system, C3 and C4 deposition was observed on the RBC membrane ( fig. 2 A) . Matched RBCs and NHS were used in all further experiments, to rule out complement activation due to ABO mismatches. Incubation of stored RBCs from either RCCs or tubes with NHS, resulted in C3 deposition on the membrane of a subpopulation of RBCs. No C4 deposition was observed ( fig. 1 B) , indicating alternative complement pathway activation. When analyzing RBCs from 7 individual donors that were incubated with the same NHS pool, the percentage of C3-positive RBCs varied between 2 and 27% for RCCs or 10 and 35% for tubes ( fig. 1 C) . However, C3 deposition was not significantly different between RBCs that were stored for a short or a long
The total population of RBCs expressed DAF, CR1, or CD59 equally well on RBCs that were stored for a short or long period of time ( table 1 ) , and no correlation was found between expression of complement regulators and C3 deposition, excluding this as explanation for the observed C3-positive subset of RBCs.
IgG Binds to Stored RBCs and Partly Coincides with Complement Activation
Using ABO mismatch as model system, IgG binding was observed on the RBC membrane ( fig. 2 B) . Matched RBCs and NHS were used in all further experiments to rule out antibody binding due to ABO mismatches. As shown in figure. 3 tween 10 and 21%, and no significant difference was observed between RBCs that were stored for a short or a long period of time ( fig. 3 B) . Next, individual differences in IgG binding and C3 deposition were investigated by cross-incubating RBCs of 5 donors with serum of the same 5 donors ( fig. 4 A) fig. 4 B) .
Phagocytic Uptake of RBCs by Macrophages Was Independent of Storage Time
Finally, we studied the phagocytic uptake of stored RBCs either opsonized with NHS or not. RBCs opsonized with anti-RhD antibody (positive control) were readily taken up, indicating that both in vitro generated allogeneic M1-and M2-type macrophages were capable of phagocytosing opsonized RBCs. M2-type macrophages phagocytosed the RhD-opsonized RBCs significantly more (64-80%) than M1-type macrophages (21-26%), independent of storage time ( fig. 5 A) . The extent of phagocytosis of both untreated RBCs and NHS-opsonized RBCs was low compared to RhD-opsonized RBCs, and no significant difference was observed between short and long stored RBCs. The percentage phagocytosis of both untreated RBCs and NHS-opsonized RBCs was lower for the M1-type macrophages (average 1%) compared to the M2-type macrophages (average 4%) ( fig. 5 B) .
Discussion
Complement deposition and/or antibody binding may contribute to rapid clearance of donor RBCs after blood transfusion. Here, we investigated whether complement activation and antibody binding occurred during RBC storage and whether this may contribute to phagocytic uptake in vitro.
No complement deposition or IgG binding was detected on stored RBCs from both RCCs and tubes stored at 2-6 ° C in the standard storage solution SAGM. However, by incubating stored RBCs with allogeneic NHS, we observed C3 deposition on a subset of RBCs from both RCCs and tubes. RCC storage bags contain plasticizers, which are not present in the tubes, that can activate the complement system [21, 22] . However, the percentage C3 deposition was somewhat lower on RBCs from the RCCs compared to those from the tubes, suggesting that under the investigated conditions plasticizers did not have a major effect on complement activation.
In contrast to a previously published study [13] , we observed that storage time of RBCs had no influence on C3 deposition and IgG binding. In addition, we observed no difference in expression of complement regulators DAF (Cromer blood group system), CR1 (Knops blood group system), and CD59 over time, while Kamhieh-Milz et al. [13] suggested that increased complement [13] used phosphate-adenine-glucose-guanosine-saline-mannitol (PAGGS-M) as storage solution, while we used SAGM. It has been described that PAGGS-M prevents initial RBC swelling and spontaneous hemolysis, and osmotic fragility of the RBCs was lower compared to RBCs stored in SAGM [23] . However, it has not been investigated whether PAGGS-M influences complement activation, antibody binding, and the expression of complement regulators.
Interestingly, we observed a large donor variation for both C3 deposition and IgG binding on RBCs. For other factors such as hemolysis as well as osmotic and mechanical fragility also large donor variations are reported [4, 24] . It has been described that genetic background and environmental factors may influence the properties of RBCs of individual blood donors, which make RBCs from some donors more prone to storage lesion than those of others [4, 24] . The amount of C3 and IgG opsonization may be an indication of the degree of storage lesion and therefore may act in the future as a biomarker for storage lesion. However, more studies are needed to investigate whether C3 and IgG opsonization on the subset of RBCs correlate with other known biomarkers of the storage lesion.
Most remarkably, even incubation with autologous serum resulted in both C3 deposition and IgG binding on RBCs. Changes are apparently induced in RBC membrane structures during blood collection and processing, which may lead to complement activation and antibody binding after transfusion.
Phagocytosis assays were performed to investigate whether the observed C3 deposition and IgG binding may contribute to clearance of stored RBCs. We observed that phagocytosis of RhD-opsonized RBCs by M1-type macrophages was significantly lower compared to that by M2-type macrophages. This is in agreement with other studies showing that monocytes activated with GM-CSF or interferon-γ (M1-type macrophages), have a decreased phagocytic capacity compared to monocytes activated with M-CSF or IL-10 (M2-type macrophages) [20, 25] . Phagocytosis of untreated and NHS-opsonized RBCs was comparable, but low compared to RhD-opsonized RBCs. Others have shown before that in case of allo-or autoantibodies, as occurring in a transfusion reaction or autoimmune hemolytic anemia, RBCs are cleared from the circulation by macrophages via Fc receptors and/or complement receptors [26, 27] . It seems that the extent of C3 deposition and/or IgG binding on stored RBCs observed in our study was not sufficient for phagocytic uptake by macrophages.
In conclusion, no C3 deposition was observed on RBCs as present in a RCC, even upon prolonged storage. However, upon incubation of stored RBCs with serum, C3 deposition and IgG binding occur on a subset of RBCs. So likely, a fraction of donor RBCs will 
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